← All trials
NCT01323062
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2011
- Primary completion
- May 14, 2014
- Completion date
- Feb 4, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 26
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University of North Carolina at Chapel HillLead sponsor
- Avid BioservicesCollaborator
- University of North Carolina at Chapel HillOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.